Biotechnology
Find Biotechnology. Search listings and reviews of retailers, specialists and services in your local area now.
JustClickLocal.com
Save
My Rating
Find Biotechnology. Search listings and reviews of retailers, specialists and services in your local area now.
JustClickLocal.com
Save
My Rating
Biotech & Pharma Sales
Sales positions open in the Biotech fields. Search & apply.
www.kellyscientific.us
Sales positions open in the Biotech fields. Search & apply.
www.kellyscientific.us
MSc in bioinformatics
International curriculum in Finland Universities of Tampere and Turku
bioinformatics.fi
International curriculum in Finland Universities of Tampere and Turku
bioinformatics.fi
Related Business Topics
Company Profiles
Abgenix, Inc.. The Group's principal activities are to develop and market fully human monoclonal antibody therapies for cancer inflammation and metaolic diseases. The Group's technology and integrated product development platform enable rapid ge...
SEE ALSO:
Profile
Acambis PLC. The Group's principal activity is researching, developing, manufacturing and selling vaccines to prevent and treat infectious diseases. Lead products are Vivotif and Arilvax. The Group operates in the United Kingdom and the United S...
SEE ALSO:
Profile
Actelion AG(ACTELION). The Group's principal activity is to discover, develop and market low molecular drugs for human health care. The Group's products include Tracleer for the treatment of pulmonary arterial hypertension and Zavesca for the tr...
Adolor Corporation. The Group's principal activity is to discover, develop and market proprietary pharmaceutical products for the treatment of pain and the side effects that are caused by current pain treatments. It's most advanced product candi...
Advanced Viral Research Corp.. The Group's principal activity is to produce, market, promote and sell pharmaceutical drugs. It is into organizational activities, research and development activities and raising capital. It operates under the trad...
Amgen Inc.. The Group's principal activities are to discover, develop, manufacture and market human therapeutics based on advances in cellular and molecular biology. The Group markets human therapeutic products in the areas of hematology, oncolo...
Arena Pharmaceuticals, Inc.. The Group's principal activities are to discover, develop and commercialize novel and improve orally available drugs that address major unmet medical needs. The Group develops and commercializes oral drugs in therape...
Ariad Pharmaceuticals Incorporated. The Group's principal activities are the discovery and development of medicines that treat cancer by regulating cell signaling with small molecules. The Group's lead product candidate, AP23573, is in multiple ...
ArQule, Inc.. The Group's principal activities are the research and development of small molecular therapeutics based on its Activated Checkpoint Therapy (ACTSM) platform. The ACT technology develops small molecule compounds that selectively kil...
Avigen, Inc.. The Group's principal activity is to develop and commercialize small molecule therapeutics and biologics to treat serious neurological and neuromuscular disorders. The Group product candidates primarily address neuromuscular spasm ...
SEE ALSO:
Profile
BB Biotech AG. The Group's principal activity is the investment in biotechnology companies, aimed particularly at the North American market. As of 31 December 2006 the Company has invested in 22 biotech holdings and in two derivatives. Acquires ...
PRODUCT SALES ACCOUNTED FOR 80% OF 2000 REVENUES; CONTRACT FEES, 13%; ROYALTIES, 4% AND OTHER REVENUES, 3%.
Biocryst Pharmaceuticals Inc. The Company's principal activity is to design, optimize and develop novel small molecule pharmaceuticals that block key enzymes essential for cancer, cardiovascular diseases, autoimmune diseases and viral infections...
Biogen, Inc.. The Group's principal activity is to develop, manufacture and market novel human therapeutic products. The Group currently sells AVONEX (r) for the treatment of relapsing multiple sclerosis (MS) and commencing in 2003, AMEVIVE (r) ...
CardioTech International, Inc.. The Group's principal activity is to develop and manufacture small bore vascular grafts or synthetic blood vessels. The vascular grafts, made of ChronoFlex, are used to replace, bypass or provide a new lining or a...
Cephalon, Inc.. The Group's principal activity is to discover, develop and market products to treat neurological disorders and cancers. The Group researches to develop suitable drugs in treatment of neurological disorders like ALS, narcolepsy, p...
Closure Medical Corporation. The Company's principal activity is to develop, manufacture and market medical tissue adhesive products for human and veterinary wound care and closure. The Company's medical tissue adhesives are used to close and se...
Cypress Bioscience, Inc.. The Group's principal activity is to develop products for the treatment of Functional Somatic Syndromes and other related chronic pain and central nervous system disorders. The Group is in the process of developing miln...
deCODE genetics, Inc.. The Group's principal activity is to develop products such as drugs, genetic diagnostic tests designed to identify genetic markers associated with elevated risk of developing a disease and services for the healthcare indus...
Deltagen, Inc.. The Group's principal activity is to provide genomics based information, products and programs. The Group's products and programs are used to discover drugs targets and drug candidates and also to accelerate pharmaceutical and bi...
Diacrin, Inc.. The Group's principal activity is to develop cell transplantation technology for treating human diseases that are characterized by cell dysfunction or cell death. The Group also develops a proprietary technology designed to modula...
Digene Corporation. The Group's principal activities are to develop, manufacture and market proprietary DNA and RNA testing systems for the screening, monitoring and diagnosis of human diseases, mainly women's cancers and infectious diseases. Th...
Discovery Partners International, Inc.. The Group's principal activity is to develop and sell instruments and associated consumables to pharmaceutical companies. The Group's generates large chemical compounds for drug discovery and provides inst...
Durect Corporation. The Group's principal activities are pioneering the treatment of chronic diseases and conditions by developing and marketing pharmaceutical systems. Its pharmaceutical systems combine engineering innovations and delivery tech...
Dusa Pharmaceuticals, Inc.. The Group's principal activity is the research, develop and marketing drugs in combination with light devices to treat or detect a variety of conditions in processes known as photodynamic therapy or photodetection. Th...
Dyax Corp.. The Group's principal activities are to discover, develop and market antibody, protein and peptide based therapeutic products for unmet medical conditions, particularly in the areas of inflammation and oncology. The two product candi...
Emisphere Technologies Incorporated. The Group's principal activity is to develop product candidates for therapeutic areas, including cardiovascular disease, diabetes, osteoporosis, growth disorders, asthma and allergies, obesity and infectious ...
Entremed Inc. The Group's principal activity is to sponsor and conduct research and development of therapeutics primarily for the treatment of cancer. The Group's lead drug candidate Panzem(R) (2-methoxyestradiol or 2ME2) is currently being test...
Enzo Biochem, Inc.. The Group's principal activities are the research, development, manufacture and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. It operates in three Segments: E...
Exelixis, Inc.. The Group's principal activity is to research and develop therapeutically and commercially valuable pharmaceutical products by leveraging its integrated discovery platform. The Group's research and discovery platform includes mod...
Gene Logic Inc.. The Group's principal activity is to develop and commercialize proprietary genomic and toxicogenomic databases, toxicogenomic services, software tools and other services. These services are organized into two segments: Genomics ...
Genelabs Technologies, Inc.. The Group's Principal Activity is to Discover And Develop Pharmaceutical Products. The Group is Currently Pursuing Regulatory Approval of Prestara (tm), Its Investigational Drug For Women With Systemic Lupus Erythema...
Generex Biotechnology Corporation. The Group's principal activity is the research and development of drug delivery systems and technology. Its current focus is the development of its proprietary technology for the administration of formulations ...
Genesis Bioventures, Inc.. The Group's principal activity is to focus on development and marketing of breast cancer risk assessment tool. The Group is a development stage company. It is involved with portfolio companies, which are involved in ca...
COMMERCIALIZES GENOMICS-BASED DRUG DISCOVERY IN THE AREAS OF HUMAN GENETIC DISEASES & DISEASES CAUSED BY PATHOGENS
SEE ALSO:
Profile
INVOLVED IN BIOTECHNOLOGY TO PROVIDE THERAPEUTIC APPLICATIONS FOR THE REPAIR OF DAMAGED OR DEGENERATIVE BONE AND SOFT TISSUE
Genta Inc. The Group's principal activity is to identify, develop and commercialize novel drugs for cancer and related diseases. The research program of the Group is focused mainly on DNA/RNA Medicines and Small Molecules. DNA/RNA medicines are ...
Applies transgenic technology to the development and production of recombinant proteins for therapeutic and diagnostic uses
Geron Corporation. The Group's principal activity is to discover, develop and commercialize therapeutic and diagnostic products for applications in oncology and regenerative medicine and research tools for drug discovery. Product development pro...
Gilead Sciences, Inc.. The Groups' principal activities are to discover, develop and market therapeutics to treat patients suffering from life-threatening diseases. It focuses its research and clinical programs on anti-infectives, antiviral, ant...
Hemispherx Biopharma, Inc.. The Group's principal activity is to develop, manufacture, market and distribute new drugs for the treatment of viral and immune based chronic disorders. Its proprietary drug technology utilizes specifically configure...
Hybridon, Inc.. The Group's Principal Activity is to Discover And Develop Therapeutics And Diagnostics Using Synthetic Dna. The Group's Activities Are Based on Two Technology Platforms: Immunomodulatory Oligonucleotide (imo) Technology That Uses...
APPLIES PROPRIETARY DNA ARRAY TECHNOLOGY OF INTEGRATED HYX GENOMICS PLATFORM TO DEVELOP GENE-BASED THERAPEUTIC PRODUCTS & TESTS
Ilex Oncology, Inc.. The Group's principal activities are to develop and commercialize a portfolio of novel treatments for both early and late stage cancers. The product Campath(R) has been approved in the United States and Europe for treating p...
Contract Research accounted for 48% of 2000 revenues and Licensed Research, 52%
Immunex Corporation. The Group's principal activity is to develop, discover, manufacture and market innovative therapeutic products. Major products of the Group include leukine, novantrone, thioplex, methotrexate, amicar, levoprome, enbrel-TM-, ...
Incyte Corp.. The Group's principal activities are to discover and develop drugs for the treatment of serious unmet medical needs. The Group is engaged in the development of proprietary small molecule drugs for the treatment of human immunodefic...
InKine Pharmaceutical Company, Inc.. The Group's principal activity is to develop and market pharmaceutical products to diagnose and treat gastrointestinal disorders. The Group markets two products, Visicol for the treatment of constipation and ...
Insite Vision Incorporated. The Company's principal activity is to develop ophthalmic pharmaceutical products for the treatment of ocular infections, glaucoma and retinal diseases. The research and development of the Company is based on propriet...
Inspire Pharmaceuticals, Inc.. The Company's principal activity is to discover, develop and market pharmaceutical products. It focuses in the ophthalmic and respiratory therapeutic areas. The Company's ophthalmic products and clinical product ca...
DEVELOPS & COMMERCIALIZES PORTFOLIO OF PRODUCT CANDIDATES FOR NEUROLOGICAL & BEHAVIORAL DISORDERS
DEVELOPS & INTENDS TO COMMERCIALIZE NEW ANTIBACTERIAL & ANTIFUNGAL DRUGS FOR THE PREVENTION OR TREATMENT OF INFECTIOUS DISEASES
Introgen Therapeutics, Inc.. The Group's principal activity is to develop gene therapy products for the treatment of cancer. The Group's product, ADVEXIN gene therapy combines the p53 gene to protect cells from becoming cancerous. The Group is d...
Isis Pharmaceuticals Incorporated. The Group's principal activity is to develop and market RNA-based drugs to treat important diseases. The Group has two segments. Drug Discovery and Development segment produces a broad proprietary portfolio of ...
La Jolla Pharmaceutical Company. The Group's Principal Activity is to Conduct Research And Development of Therapeutics For The Treatment of Certain Life-Threatening Antibody-Mediated Diseases. The Diseases Include Autoimmune Conditions Such as S...
Large Scale Biology Corporation. The Group's Principal Activity is to Develop Therapeutic Products For Treatment of Cancer And Prevention of Infectious Diseases. The Product Categories Include Vaccines For The Treatment of Cancer And The Treatme...
Ligand Pharmaceuticals Inc. The Group's principal activities are to discover, develop and market drugs for the treatment of cancer, skin diseases, osteoporosis, metabolic and cardiovascular diseases. The major trademarks of the Group's are Ligan...
THE COMPANY DEVELOPS NOVEL TECHNOLOGIES FOR THE DISCOVERY OF GENE EXPRESSION PATTERNS AND GENOMIC VARIATIONS
Martek Biosciences Corporation. The Group's principal activity is to develop, manufacture and sell naturally produced products derived from microalgae, fungi and other microbes. The Group's products and services include specialty, nutritional oi...
Maxygen Incorporated. The Group's principal activities are focused on the discovery, development and commercialization of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions. It currently ...
Medarex Incorporated. The Group's principal activities are to discover and develop human antibody-based therapeutic products. The Group uses its proprietary technology platform, the UltiMAb Human Antibody Development System to rapidly create and...
MediChem Life Sciences, Inc.. The Company provide drug discovery, research and development chemistry services to biotechnology and pharmaceutical companies. These services include proteomics, the creation of customized compound libraries, medici...
Medicines Company (The). The Group's principal activities are to acquire, develop and marketing of late-stage development drugs. The Group's products are Angiomax, Angiox and CleviprexTM. Angiomax is used as an anticoagulant in combination with ...
MedImmune, Inc.. The Group's principal activity is to discover, develop, manufacture and market products for treatment and prevention of infectious diseases, immune system disorders and cancer. It markets four products Synagis, Ethyol, FluMist a...
Millennium Pharmaceuticals Inc. The Group's principal activity is to develop and market proprietary therapeutic products. The research and development activities are focused on the disease areas of cancer, cardiovascular disease and inflammatory...
Myriad Genetics Inc. The Group's principal activity is to develop and market novel therapeutic and molecular diagnostic products. It operates in three segments: Research, Predictive Medicine and Drug Development. The Research segment focuses on ...
ANTIBODY PRODUCTS ACCOUNTED FOR 68% OF 2000 REVENUES AND PHARMACEUTICAL PRODUCTS, 32%
Neogen Corporation. The Group's principal activity is to develop, manufacture and market diverse line of products dedicated to food and animal safety. The Group operates in two segments: Food Safety and Animal Safety. The Food Safety segment pro...
Neorx Corporation. The Group's Principal Activity is to Develop Products For Targeted Delivery of Anti-Cancer Agents, Including Radiopharmaceuticals, to Tumor Sites. The Group's Product Strtm (skeletal Targeted Radiotherapy) is Developed to Trea...
Neose Technologies Incorporated. The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins .Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to...
Neurobiological Technologies, Inc.. The Group's principal activity is to acquire and develop central nervous system (CNS) related drug candidates. The Group's focus is on therapies for neurological conditions that occur in connection with ischem...
Neurocrine Biosciences Inc. The Group's principal activities are to discover and develop pharmaceutical products for neurologic and endocrine diseases and disorders. The product candidates in clinical development include Indiplon for insomnia, G...
Neurogen Corporation. The Group's principal activities are to discover and develop new drugs for the treatment of neurological, inflammatory, pain and metabolic disorders. Through its Accelerated Intelligent Drug Discovery (TM) platform, it disc...
NexMed, Inc.. The Group's principal activity is to design, develop and market therapeutic products based on proprietary delivery systems. The Group develops products for topical treatments including cream, lacquer, gel, patch and tape products b...
LABORATORY TESTING ACCTD FOR 88% OF 1999 REVS; CONTRACT REVS FROM UNRELATED PARTY, 6%; GRANT REVS, 5% & LICENSE & OTHER REVS, 1%
SEE ALSO:
Profile
Oxford BioMedica plc. The Group's principal activity is the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Group has expertise in gene delivery, as well as in-house clinical, regulatory a...
Pain Therapeutics, Inc.. The Company's principal activity is to develop drugs for use in pain management. It operates in the clinical development and commercialization of novel painkillers. The company is developing two oral, small molecule drug...
Pharmaceutical Product Development, Incorporated. Leading global contract research organization (CRO) providing discovery, development and post-approval services to pharmaceutical, biotechnology, medical device, academic and government organizat...
SEE ALSO:
Profile
Protherics PLC. The Group's principal activity is researching, developing, manufacturing and selling pharmaceutical products and potential drugs for the treatment of human diseases. The Group's product development is mainly concentrated on the a...
Protherics PLC. The Group's principal activity is researching, developing, manufacturing and selling pharmaceutical products and potential drugs for the treatment of human diseases. The Group's product development is mainly concentrated on the a...
Quest BioTechnology, Inc. conducts research and development of biotechnological processes and human care products. The company also acquires interest in entities, which own such products. The company through its subsidiaries has entered into agr...
Quest Diagnostics Incorporated. The Group's principal activities are to provide diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health. The G...
Regeneration Technologies, Inc.. The Group's principal activities are to process and distribute human musculoskeletal and other comprehensive healing and natural tissue products. Surgeons use these tissues to repair and promote the healing of a ...
Develops technology for producing drugs based on ribozymes for treatment of solid tumour cancers, breast cancer and Hepatitis B
Sangamo Biosciences, Inc.. The Group's principal activities are to conduct research, develop and commercialization of DNA binding proteins for the therapeutic regulation and modification of disease-associated genes. The Group's gene recognition-...
Tanox, Inc.. The Group's principal activity is to discover and develop biotherapeutics based on monoclonal antibody technology. It develops innovative therapeutic agents for the treatment of immune-mediated diseases, inflammation, infectious dis...
Targeted Genetics Corporation. The Group's Principal Activities Are to Develop Gene Therapy And Cell Therapy Products And Technologies For The Treatment of Acquired And Inherited Diseases. The Gene Therapy Products Are Designed to Treat Diseases...
SEE ALSO:
Profile
Tepnel Life Sciences PLC. The Group's principal activities are researching, developing and commercialising a range of products and services within the life sciences, pharmaceutical and food safety industries. It has two business classes, Molecul...
SEE ALSO:
Profile
Helio Biotech AG Formerly known as Trace Biotech AG. The Company's principal activity is the development, manufacture and marketing of biotechnological systems, devices and equipment. Its products include automated systems for process monitoring...
Transkaryotic Therapies Inc. The Group's principal activity is to research, develop and market therapeutics, primarily for the treatment of rare genetic diseases caused by protein deficiencies. It sells Replagal, an enzyme replacement therapy fo...